162 related articles for article (PubMed ID: 15860347)
21. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
Baumann MH; Ayestas MA; Dersch CM; Partilla JS; Rothman RB
Ann N Y Acad Sci; 2000 Sep; 914():172-86. PubMed ID: 11085319
[TBL] [Abstract][Full Text] [Related]
22. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
Baumann MH; Ayestas MA; Dersch CM; Rothman RB
Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
[TBL] [Abstract][Full Text] [Related]
23. Herpes virus-mediated preproenkephalin gene transfer in the ventral striatum mimics behavioral changes produced by olfactory bulbectomy in rats.
Primeaux SD; Wilson MA; Wilson SP; Guth AN; Lelutiu NB; Holmes PV
Brain Res; 2003 Oct; 988(1-2):43-55. PubMed ID: 14519525
[TBL] [Abstract][Full Text] [Related]
24. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
[TBL] [Abstract][Full Text] [Related]
25. Neonatal olfactory bulbectomy enhances locomotor activity, exploratory behavior and binding of NMDA receptors in pre-pubertal rats.
Flores G; Ibañez-Sandoval O; Silva-Gómez AB; Camacho-Abrego I; Rodríguez-Moreno A; Morales-Medina JC
Neuroscience; 2014 Feb; 259():84-93. PubMed ID: 24295633
[TBL] [Abstract][Full Text] [Related]
26. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats.
Prins J; Denys DA; Westphal KG; Korte-Bouws GA; Quinton MS; Schreiber R; Groenink L; Olivier B; Korte SM
Eur J Pharmacol; 2010 May; 633(1-3):55-61. PubMed ID: 20153745
[TBL] [Abstract][Full Text] [Related]
27. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M
Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657
[TBL] [Abstract][Full Text] [Related]
28. Olfactory bulbectomy reduces cerebral glucose utilization: 2-[14C]deoxyglucose autoradiographic study.
Skelin I; Sato H; Diksic M
Brain Res Bull; 2008 Jul; 76(5):485-92. PubMed ID: 18534256
[TBL] [Abstract][Full Text] [Related]
29. Olfactory bulbectomy increases food intake and hypothalamic neuropeptide Y in obesity-prone but not obesity-resistant rats.
Primeaux SD; Barnes MJ; Bray GA
Behav Brain Res; 2007 Jun; 180(2):190-6. PubMed ID: 17420059
[TBL] [Abstract][Full Text] [Related]
30. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study.
Watanabe A; Tohyama Y; Nguyen KQ; Hasegawa S; Debonnel G; Diksic M
J Neurochem; 2003 Apr; 85(2):469-75. PubMed ID: 12675923
[TBL] [Abstract][Full Text] [Related]
31. Riluzole rapidly attenuates hyperemotional responses in olfactory bulbectomized rats, an animal model of depression.
Takahashi K; Murasawa H; Yamaguchi K; Yamada M; Nakatani A; Yoshida M; Iwai T; Inagaki M; Yamada M; Saitoh A
Behav Brain Res; 2011 Jan; 216(1):46-52. PubMed ID: 20620171
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
33. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Galineau L; Belzung C; Kodas E; Bodard S; Guilloteau D; Chalon S
Brain Res Dev Brain Res; 2005 Feb; 154(2):165-76. PubMed ID: 15707670
[TBL] [Abstract][Full Text] [Related]
34. The olfactory bulbectomized rat as a model of depression: an update.
Kelly JP; Wrynn AS; Leonard BE
Pharmacol Ther; 1997; 74(3):299-316. PubMed ID: 9352586
[TBL] [Abstract][Full Text] [Related]
35. Chronic therapy with citalopram decreases regional cerebral glucose utilization in OBX, and not sham-operated, rats: an autoradiographic study.
Skelin I; Sato H; Kovacević T; Diksic M
Psychopharmacology (Berl); 2009 Dec; 207(2):315-23. PubMed ID: 19760282
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.
Eisenstein SA; Holmes PV; Hohmann AG
Synapse; 2009 Nov; 63(11):941-50. PubMed ID: 19593824
[TBL] [Abstract][Full Text] [Related]
37. Treadmill exercise improves depression-like symptoms by enhancing serotonergic function through upregulation of 5-HT
Shin MS; Park SS; Lee JM; Kim TW; Kim YP
J Exerc Rehabil; 2017 Feb; 13(1):36-42. PubMed ID: 28349031
[TBL] [Abstract][Full Text] [Related]
38. Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.
Creed MC; Hamani C; Bridgman A; Fletcher PJ; Nobrega JN
J Neurosci; 2012 Jul; 32(28):9574-81. PubMed ID: 22787043
[TBL] [Abstract][Full Text] [Related]
39. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.
Suyama JA; Sakloth F; Kolanos R; Glennon RA; Lazenka MF; Negus SS; Banks ML
J Pharmacol Exp Ther; 2016 Jan; 356(1):182-90. PubMed ID: 26645638
[TBL] [Abstract][Full Text] [Related]
40. Role of aversively motivated behavior in the olfactory bulbectomy syndrome.
Primeaux SD; Holmes PV
Physiol Behav; 1999 Aug; 67(1):41-7. PubMed ID: 10463627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
